National Institute for Health and Clinical Excellence (NICE)
NICE says non-surgical options should be offered first for stress urinary incontinence or pelvic organ prolapse
Women should be offered the treatment option of her choice, in discussion with her clinician.
A full range of non-surgical options should be offered to women for stress urinary incontinence or pelvic organ prolapse before any operations, NICE has said.
There are a number of non-surgical options for both urinary incontinence and pelvic organ prolapse, which should be considered before surgery. The non-surgical options for urinary incontinence include:
- Lifestyle interventions
- Physical therapies
- Behavioural therapies
Non-surgical options for pelvic organ prolapse include:
- Lifestyle modification
- Topical oestrogen
- Pelvic floor muscle training
- Pessary management
Where surgery is offered, if a woman’s chosen intervention is not available from the consulting surgeon, she should be referred to an alternative surgeon, the draft guideline recommends.
Surgical interventions using surgical mesh/tape should only be considered when other non-surgical options have failed or are not possible.
A national database should be set up to record all procedures involving the use of surgical mesh/tape in operations for stress urinary incontinence or pelvic organ prolapse to help with future decision making.
In the cases where it is agreed to use surgical mesh/tape, women must be fully informed of the risks, the independent NICE committee said in the draft guideline.
Sir Andrew Dillon, chief executive of NICE, yesterday said: “Our independent advisory committee looked at a range of evidence for interventions for urinary incontinence and pelvic organ prolapse in women and made a series of detailed recommendations, using the best evidence currently available.
“It is important that every woman is supported to make decisions that are right for her, consents to a procedure, and fully understands the benefits and risks of the procedure being offered before consenting to it.
“Where surgical mesh/tape could be an option, there is almost always another intervention recommended in our guideline, which does not involve surgical mesh/tape. If a surgeon cannot provide a full range of choices to the patient, then she should be referred to one who can.
“Surgeons must also record any intervention using surgical mesh/tape in a national database.
“The guideline committee was asked to look at a range of interventions and examine the evidence for them. Importantly, our recommendations offer women a range of options for treatment that don’t involve the use of surgical mesh/tape.”
In July a national ‘pause’ was announced by the government on the use by the NHS of surgical mesh/tape to treat stress urinary incontinence and for urogynaecological prolapse where the mesh is inserted through the vaginal wall. This ‘pause’ takes the form of a high vigilance restriction period during which certain conditions apply.
This will remain in place until a number of conditions are met including:
- Registering all operations and any complications on a national database
- Surgery being performed by specialist surgeons based at specialist centres
A follow up appointment should be offered within six months to all women who have had urinary incontinence or prolapse surgery.
The draft guideline also recommends how complications associated with surgical mesh/tape surgery should be assessed and managed.
Consultants at centres specialising in the diagnosis and management of surgical mesh/tape-related complications should develop an individualised investigation plan for each woman with suspected or confirmed mesh-related complications.
Complications related to the device should be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) and details of the complications should be collected in a national registry.
There are a number of recommendations included in the guideline for surgical mesh/tape-related complications. These include:
- Referring women who suffer a suspected surgical mesh/tape-related complication to a urogynaecologist, urologist or colorectal surgeon for specialist assessment.
- Referring women with a confirmed surgical mesh/tape-related complication, or unexplained symptoms after a surgical mesh/tape procedure, to a consultant at a regional centre specialising in the diagnosis and management of surgical mesh/tape-related complications.
- The development of an individualised investigation plan for each woman with suspected or confirmed surgical mesh/tape-related complications.
Registered stakeholder organisations can now submit comments on these proposed recommendations until 19 November 2018.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Thousands of adults with chronic lymphocytic leukaemia to benefit from new treatment option18/01/2019 13:15:00
Thousands of people will benefit as NICE recommends venetoclax with rituximab for adults with relapsed or refractory chronic lymphocytic leukaemia.
More donor livers could be used for transplantation thanks to exciting new development, NICE says16/01/2019 14:15:00
Procedure will extend the life of a donor liver by double the length of time compared to now.
NICE guideline set to address variation in provision of services for adults with cerebral palsy16/01/2019 09:15:00
NICE has published its guideline on the care and support needs of adults with cerebral palsy.
Sharing end of life decisions: Carrying out mum’s wishes11/01/2019 14:15:00
Blog posted by: Annabel Dawson, lay reviewer for National Institute for Health Research (NIHR), 10 January 2019.
New migraine drug not cost-effective NICE says in draft guidance10/01/2019 14:05:00
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in draft guidance published today.
Hundreds more children and adults eligible for cochlear implants on the NHS07/01/2019 09:15:00
Hundreds more people with severe to profound deafness are expected to be eligible for cochlear implants each year, due to updated NICE guidance.
New and upgraded roads should prioritise pedestrians, cyclists and public transport over motorised vehicles04/01/2019 14:15:00
Physical inactivity is responsible for one in six deaths and is believed to cost the UK £7.4 billion each year, including £900 million to the NHS.
Third biological treatment gives more choice for people with severe asthma04/01/2019 12:20:00
Another potentially life-changing treatment should be available to people with a severe form of asthma, NICE says.